Correlation Between Dyadic International and Acurx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on Dyadic International and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Acurx Pharmaceuticals.
Diversification Opportunities for Dyadic International and Acurx Pharmaceuticals
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Dyadic and Acurx is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of Dyadic International i.e., Dyadic International and Acurx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dyadic International and Acurx Pharmaceuticals
Given the investment horizon of 90 days Dyadic International is expected to generate 0.98 times more return on investment than Acurx Pharmaceuticals. However, Dyadic International is 1.02 times less risky than Acurx Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Acurx Pharmaceuticals LLC is currently generating about -0.28 per unit of risk. If you would invest 105.00 in Dyadic International on September 13, 2024 and sell it today you would earn a total of 55.00 from holding Dyadic International or generate 52.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyadic International vs. Acurx Pharmaceuticals LLC
Performance |
| Timeline |
| Dyadic International |
| Acurx Pharmaceuticals LLC |
Dyadic International and Acurx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyadic International and Acurx Pharmaceuticals
The main advantage of trading using opposite Dyadic International and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.| Dyadic International vs. Puma Biotechnology | Dyadic International vs. Iovance Biotherapeutics | Dyadic International vs. Sarepta Therapeutics | Dyadic International vs. Day One Biopharmaceuticals |
| Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |